Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Post by KurtsMgurtson Feb 12, 2021 1:07pm
617 Views
Post# 32553715

Updated Revenue Model

Updated Revenue Model I have updated my Revenue model to reflect an average of 12,000 tests/week in sales for Q1 and Q2. As tests are set to ramp up from the recently mentioned 12,000 tests per week this is considered a conservative estimate, given managements continued ability to execute. 

I calculated the FMV of DM.V stock based on my revenue multiples (average of annualized muliple of Q mentioned and 3 prior Qs)

Q3 2020: $.13

Q4 2020: $.18 

Q1 2021: $.41

Q2 2021: $.63

Link to Excel: https://ceo.ca/dm?3d2736a84e79

Please refer to my last post for sources used to corroborate reasonability of revenue multiple's. 

KurtsMgurts
<< Previous
Bullboard Posts
Next >>